Retinol; Retinyl Acetate; Retinyl Palmitate
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
Retinol; Retinyl Acetate; Retinyl Palmitate is listed in Annex III and may only be used under the conditions shown in this record. Maximum concentration in this record: (a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE.
Record details
Maximum concentration
(a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE
Product type
Other restrictions
From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 May 2027 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.
Warnings
For any cosmetic product containing Retinol, Retinyl Acetate or Retinyl Palmitate the following, labelling is obligatory: ‘Contains Vitamin A. Consider your daily intake before use’.
INCI glossary name
Retinol; Retinyl Acetate; Retinyl Palmitate
Chemical name
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
Regulatory information
Regulation
(EU) 2024/996
Identified ingredients
Key data
Inventory links for Retinol; Retinyl Acetate; Retinyl Palmitate
RETINOL
Related records for Retinol; Retinyl Acetate; Retinyl Palmitate
Direct matches are limited for this record, so nearby entries from Annex III are shown as well.
Pinene
What Annex III means for Retinol; Retinyl Acetate; Retinyl Palmitate
Retinol; Retinyl Acetate; Retinyl Palmitate is a restricted substance under Annex III of EU Cosmetics Regulation 1223/2009. Its use in cosmetics is only permitted under the specific conditions set out in the entry above, including applicable concentration limits, product type restrictions and required warning statements.
When including this substance in a formulation, all conditions — maximum concentration, product scope and warning labels — must be met simultaneously. Compliance with one condition does not override the others.
This record is linked to 3 CosIng inventory ingredients for name and identifier cross-reference. The page also surfaces 11 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Ensure formulation concentration does not exceed: (a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE
- Confirm product type compatibility: (a) Body lotion (b) other leave-on and rinse-off products
- Include required warning statement on product label.
- Document conditions of use in the Product Information File (PIF).
Frequently asked questions
Source note for Annex III record Retinol; Retinyl Acetate; Retinyl Palmitate
This page summarizes one Annex III record for Retinol; Retinyl Acetate; Retinyl Palmitate from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex III conditions for Retinol; Retinyl Acetate; Retinyl Palmitate, but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Retinol; Retinyl Acetate; Retinyl Palmitate and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Retinol; Retinyl Acetate; Retinyl Palmitate side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex III and compare regulatory conditions across substances in this annex.
Open Annex III